CLINICAL_TRIALS ClinicalTrials.gov record update

Phase I/II Study of CaspaCIDe® T Cells From an HLA-Partially Matched Family Donor After Negative Selection of TCR αβ+T Cells in Pediatric Patients Affected by Hematological Disorders

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03301168
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:35.489332+00:00
Published At: 2022-07-12T00:00:00+00:00
Record Updated At: 2022-07-12
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Acute Lymphoblastic Leukemia", "Leukemia, Acute Myeloid (AML), Child", "Lymphoma, Non-Hodgkin", "Myelodysplastic Syndromes", "Primary Immune Deficiency Disorder", "Osteopetrosis", "Cytopenia", "Hemoglobinopathy in Children", "Anemia, Aplastic"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2022-07-12"
protocolSection.identificationModule.nctId: "NCT03301168"
protocolSection.identificationModule.officialTitle: "Phase I/II Study of CaspaCIDe\u00ae T Cells From an HLA-Partially Matched Family Donor After Negative Selection of TCR \u03b1\u03b2+T Cells in Pediatric Patients Affected by Hematological Disorders"
protocolSection.statusModule.overallStatus: "ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases: ["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.